You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
HUTCHMED receives full NMPA approval for ORPATHYS in China for MET exon 14 skipping NSCLC
Login
Username:

Password:


Related Headlines

Rakuten Medical expands academic access to IR700 dye

Insilico Medicine signs co-development collaboration agreement with Hygtia Therapeutics

HistoIndex partners Houston Research Institute

GSK agrees to acquire RAPT Therapeutics to strengthen food allergy pipeline

Alcami acquires RTP facility in Durham, NC

Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis

EMA validates Daiichi Sankyo's ENHERTU plus pertuzumab application for first-line HER2 positive metastatic breast cancer

Immunovia gains California approval for PancreaSure and begins commercial rollout

Profusa launches Lumee tissue oxygen system for CRO market

Zylox-Tonbridge agrees staged acquisition of Germany's Optimed

European Commission approves Sobi's Aspaveli for rare kidney diseases

Frontage Laboratories commences GMP facility operations

Myqorzo and Redemplo receive regulatory approval in China

AVEO Oncology reports first patient dosed in front-line AML combination study of ficlatuzumab

GenomOncology and OHSU Knight Diagnostics Lab partner to enhance clinical trial matching for cancer patients

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026